Hyejin Cho

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 8

Top Topics

Acinetobacter Baumannii

Walled Carbon Nanotubes

Multidrug Resistant

Cystic Fibrosis

Top Venues

This page only lists publications with an associated author ORCID identifier.

Publications

Hyejin Cho, Tesalonika Sondak, Kwang-Sun Kim
Characterization of Increased Extracellular Vesicle-Mediated Tigecycline Resistance in Acinetobacter baumannii . Pharmaceutics 15 (4) (2023)
Hyejin Cho, Tesalonika Sondak, Kwang-Sun Kim
Characterization of Increased Extracellular Vesicle-Mediated Tigecycline Resistance in Acinetobacter baumannii . Pharmaceutics 15 (4) (2023)
Hyejin Cho, Tesalonika Sondak, Kwang-Sun Kim
Characterization of Increased Extracellular Vesicle-Mediated Tigecycline Resistance in Acinetobacter baumannii . Pharmaceutics 15 (4) (2023)
Hyejin Cho, Tesalonika Sondak, Kwang-Sun Kim
Characterization of Increased Extracellular Vesicle-Mediated Tigecycline Resistance in Acinetobacter baumannii . Pharmaceutics 15 (4) (2023)
Atanu Naskar, Hyejin Cho, Kwang-Sun Kim
A Nanocomposite with Extracellular Vesicles from Lactobacillus paracasei as a Bioinspired Nanoantibiotic Targeting Staphylococcus aureus . Pharmaceutics 14 (11) (2022)
Hyejin Cho, Kwang-Sun Kim
Repurposing of Ciclopirox to Overcome the Limitations of Zidovudine (Azidothymidine) against Multidrug-Resistant Gram-Negative Bacteria. Pharmaceutics 14 (3) (2022)
Atanu Naskar, Hyejin Cho, Sohee Lee, Kwang-Sun Kim
Biomimetic Nanoparticles Coated with Bacterial Outer Membrane Vesicles as a New-Generation Platform for Biomedical Applications. Pharmaceutics 13 (11) (2021)
Hyejin Cho, Atanu Naskar, Sohee Lee, Semi Kim, Kwang-Sun Kim
A New Surface Charge Neutralizing Nano-Adjuvant to Potentiate Polymyxins in Killing Mcr-1 Mediated Drug-Resistant Escherichia coli. Pharmaceutics 13 (2) (2021)